Healthvista India IPO Particulars & Guidance at Chanakyanipothi.com, India`s Oldest & the most Trusted Investment website for coming up IPO. Operational since 8th December 1999, this is the Only Investment website in India, which has successfully completed 23 Years.
    healthvista India IPO particulars & guidance

     

    Healthvista India IPO Guidance
    Will update soon

    Healthvista India IPO Grey Market updates
    # For latest updates, Click

    Healthvista India IPO Subscription Status
    Will update once the IPO opens.

    Healthvista India IPO Promoters
    The company is a professionally managed company and doesnot have an identifiable promoter

    Healthvista India IPO Particulars & Guidance: About the Company

    Healthvista India is the leading out-of-hospital healthcare provider in India, based on revenue and highest market share of 21% of the organised out-of-hospital healthcare market in Fiscal 2021, as well as in terms of the number of cities covered as of December 31, 2021. Under its well established brand Portea, it provides a comprehensive range of out-of-hospital healthcare services, including primary care, geriatric (elderly) and palliative (end-of-life) care, intensive care unit (“ICU”) care, post-operative and post-hospitalization care, chronic care, mother and baby care and cancer care, all at home. It also distributes specialty pharmaceuticals and provide “point of care” medical equipment for sale and rental. As of March 31, 2022, it had established 40 offices across India, entered into agreements with 63 hospitals, 80 corporates, eight insurers and 11 insurance third party administrators (“TPAs”), to provide out-of-hospital healthcare services to their patients, employees and insured customers, respectively.
    It also works with reputed hospital-associated physicians as well as independent physicians and other key industry opinion leaders to provide out-of-hospital healthcare support requirements of their patients. As of March 31, 2022, it had developed relationships with 3,058 clinicians and had established formal arrangements with over 14 key opinion leaders across India. As of March 31, 2022, it employed or engaged 3,123 healthcare personnel, including 362 full-time employees on its rolls and 2,761 personnel engaged through third party contract arrangements. Between its incorporation and March 31, 2022, it had served over 1,200,000 unique patients (including patients under government schemes) across India across a diverse range of age and medical conditions.

    Market Opportunity
    The healthcare industry in India has grown at a CAGR of 14.54% from US$ 99 billion in 2013 to US$ 257 billion in 2020, and is expected to grow at a CAGR of 20.5% from 2020 to reach US$ 870 billion by 2027. Approximately 60% of healthcare requirements in India can be met through out-of-hospital healthcare services. Various aspects of medical care, including consultation, diagnostics, monitoring
    and treatment for chronic care, post-hospitalisation care, nursing, rehabilitation, home-based ICUs, cancer care, stroke rehabilitation and other neurological conditions, chronic kidney disorder, chemotherapy at home, palliative care and other non-urgent healthcare services are capable of being provided at home, resulting in cost effective treatment solutions including avoiding unnecessary medical costs, and offering greater convenience for patients who are able to receive quality medical care and treatment at home. (Source: F&S Report) In 2020, the Indian out-of-hospital healthcare market in India was US$ 5.1 billion. Of this, the organized market constituted 3.2% and it had a market share of 21% of the organized market.
    The total market for out-of-hospital healthcare is expected to grow at a CAGR of 17.5% from US$ 6.03 billion in 2021 to US$ 15.87 billion in 2027, but a significantly higher CAGR of 32.3% is expected for the organized segment.

    For more information, click www.portea.com

    Objects of the IPO
    The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
    1. Funding the working capital requirements of its Material Subsidiary, namely Medybiz Pharma Private Limited
    2. Re-payment/ pre-payment of certain indebtedness availed by the Company
    3. Purchase of medical equipment
    4. Marketing and brand building activities
    5. Inorganic growth initiatives and general corporate purpose.

    Healthvista India IPO Particulars & Guidance

    Healthvista India IPO Details & Analysis
    IPO opens on  ? ,2023 
    IPO closes on  ? ,2023 
    Issue Type Book Built Issue IPO
    Issue Size ? Sh /Rs ? Cr
    * Fresh Issue ? Sh /Rs 200 Cr
    * Offer for Sale  56,252,654 Shares /Rs ? Cr
       
    Face Value per share: Rs. 1
    Price Band  Rs. ?
    Retail Discount  Rs 0 per share
    Employee discount  Rs. 0 per share
    Retail Lot Size  ? Shares
    Listing will at  BSE, NSE
    Shares offered to Shares Rs. in Cr
    QIB (10 %) 
    NII (30 %) 
    RII (60 %) 
    Employees 
    Total Shares 
    Retail portion will be oversubscribed by  ? Forms.
    How much Shares to Apply? Net of RII discount
    Min Retail Application – Sh Rs. –
    Max Retail Application  – Sh Rs. –
    Small HNI (Min) application  – Sh Rs. –
    Small HNI (Max) application – Sh Rs. –
    Big HNI Application – Sh Rs. –
    Healthvista India IPO Tentative timetable
    IPO opens on ? 2023
    IPO Closes on ? 2023
    IPO Allotment on  ? 2023
    Unblocking of ASBA  ? 2023
    Credit of Shares ? 2023
    Listing on ? 2023
    Registered Office of the Company
    No.69/B, 1st Cross, 1st Stage, Domlur Layout, Bengaluru 560 071, Karnataka, India
    Lead Managers 
    SBI Capital Markets, IIFL Securities, JM Financial
    Registrar to IPO
    Link Intime India Private Limited
    Healthvista India IPO Financial & Analytical Ratios
    Year Total Income Net Profit EPS RoNW
      Rs. in Cr Rs.in Cr Rs. %
    2019-20 162.06 (48.01) (7.63) (7.37)
    2020-21 130.38 (37.01) (5.88) (5.39)
    2021-22 (9M) 119.11 (34.86) (4.87) (190)
    Book Value of the Share on 31.09.2022 Rs.(0.88)    
    Book Value of the Share after the FPO Rs.?    
    Offer Price at Cap   Rs. ?    
    Ratio Analysis
    Upper Price /last EPS ?
    Upper Price/Book Value Ratio ?
    Upper Price/BV after IPO  ?

    Healthvista India IPO Particulars & Guidance
    Peer Comparison
    There are no identifiable listed peers of the Company.

    # This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

    >>Go to SME IPOs Section: Click
    >>Get Good Staff or Job, Click: Staffavailable.com
    >>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
    >>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
    >>Study Stock Research Reports, Click: AnalysisLibrary.com
    >>
    Interested in Crossword Puzzles? Click: Magajmari.com

    Leave a Reply

    Your email address will not be published. Required fields are marked *